© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Chloramphenicol unlocked new pathways in antibiotic therapy starting in the late 1940s. Researchers in Venezuela discovered this compound in Streptomyces venezuelae soil bacteria, hoping to turn the tide against infectious diseases. Its early days saw life-saving victories over typhus and meningitis, earning a reputation among doctors facing few other options. Resistance barely held a place in common talk back then. The connection between this antibiotic and deadly infections like bacterial meningitis runs deep in medical memories, especially before the age of safer alternatives. While many drugs fall quickly out of use, chloramphenicol sticks around in some countries, especially wherever the price of modern medicines becomes the highest barrier.
Chloramphenicol serves as a broad-spectrum antibiotic. Doctors turn to this molecule for especially tough bugs, like Salmonella typhi, and in low-resource areas that struggle with costlier options. On pharmacy shelves, the core forms show up as tablets, capsules, syrups, and eye drops. A few veterinarians find it valuable for treating animal infections too, breaching the borders between human and animal medicine. The structure, small and effective, slides through cell walls and boils down to practical chemistry: an aromatic nitrobenzene ring paired with a dichloroacetyl group and a secondary alcohol. This makeup puts it in fights that some antibiotics never touch.
Most lab techs find chloramphenicol as a fine, white or creamy powder that tastes bitter and holds a faint smell. At room temperature, it rests stable. Water handles only a little before dissolving; alcohol and ether do a better job. The melting point sits near 150 degrees Celsius, a number trusted in pharmaceutical quality control to spot any fake or contaminated batches. With a molecular formula of C11H12Cl2N2O5, it offers a molecular weight of about 323 grams per mole; this matters most in prepping solutions for accurate dosing or research. Chemists work confidently with this substance, as its predictable profile often spares them surprises during compounding.
Manufacturers list chloramphenicol’s strength—often 250mg or 500mg per tablet or capsule—prominently on the label, because dose precision makes the difference between cure and harm. Syrup forms for children stick around 125mg per 5ml, balancing safety and effectiveness. Producers need to note the production date and expiry, as degraded chloramphenicol risks patient health by shifting into toxic by-products. The World Health Organization and many national authorities keep basic standards for purity, residual solvents, moisture, and contaminants. Pharmacies and hospitals pay close attention to batch numbers for quick tracing during recalls or adverse-event reports, a system that grew stronger after the early days of antibiotic manufacturing mistakes.
The original method pulled chloramphenicol straight from soil bacteria, but widespread demand changed the approach fast. Now, chemical synthesis rules—you won’t find many pharma labs still relying on fermentation. Most recipes start with methyl 2-nitroacetophenone, which undergoes reduction and acylation using dichloroacetyl chloride. Skilled chemists use modern filtration, crystallization, and washing steps to guarantee high yield and minimal by-product. Cost-cutting corners in this route risk impure drugs, so reputable manufacturing holds tightly to protocol and documentation, not only for patient safety but to keep up with inspections by international regulators.
Chloramphenicol’s reactive points invite a range of chemical tweaks. The nitro group grabs attention for reductions—turning it into an amine group, for instance, changes the way it fights bacteria. Some labs modify the dichloroacetyl moiety, chasing after derivatives with better absorption or less toxicity. Esterification, where the molecule’s alcohol group hooks up with different acids, creates prodrugs with slower release. Scientists around the world work on analogues hoping for an answer to increasing antimicrobial resistance, or reach for molecules less likely to cause bone marrow suppression, chloramphenicol’s infamous Achilles’ heel.
People in the business know chloramphenicol goes by more than one name. In hospitals you may hear “chloromycetin” from older professionals; generic drugs stick to “chloramphenicol”. Less formally, it appears as D(-)-threo-2,2-dichloro-N-(β-hydroxy-α-(hydroxymethyl)-p-nitrophenethyl)acetamide in academic circles, though few outside chemistry classrooms speak it aloud. This multiplicity of names, plus various foreign-language versions, sometimes creates confusion in border trade or in parts of the world with counterfeit drug problems. Drug agencies try to harmonize these through international naming conventions, though no system catches every variation in every corner.
Chloramphenicol’s impact hits beyond the bacteria it targets. It crosses the blood-brain barrier and accumulates in tissues, making dosing not just a clinical guess but a critical science. Everyone in healthcare knows the risks of fatal aplastic anemia and gray baby syndrome, especially in newborns lacking mature liver enzymes. Hospitals enforce double-checks on dose and duration, and strict formulas limit veterinary use to avoid residues in milk or meat. On the factory floor, workers wear gloves and masks, as inhaling or absorbing the pure powder poses risks of allergic reaction or more serious blood disorders. Adequate ventilation becomes a non-negotiable feature wherever chloramphenicol enters or leaves the lab.
Doctors worldwide reach for chloramphenicol to treat serious infections: meningitis, typhoid, certain eye infections. In places pinched by cost or supply chain gaps, it fills the gap left by pricey cephalosporins and carbapenems. Eye drops control conjunctivitis, especially in crowded settings like refugee camps or schools during outbreaks. Laboratories in developing countries sometimes prefer it because reliable test protocols depend on its well-understood actions. Animal health workers still use it for respiratory and intestinal issues, but watchdogs clamp down on misuse due to the threat of antibiotic residues in food products.
Chloramphenicol’s legacy earned it a spot in research journals that’s survived decades of pharmaceutical progress. Scientists study structure-activity relationships, hoping to crack the code for new derivatives with fewer side effects but equal punch against bacteria. Drug resistance research leans heavily on chloramphenicol as a test case because mechanisms like acetyltransferase modification map well onto similar antibiotics. Pharmaceutical teams explore liposomal or nanoparticle delivery to tweak release time and tissue targeting—hoping improved formulations deliver a better safety margin. Academic consortia in Asia and Africa, where infectious diseases surge and expensive therapies prove out of reach, keep chloramphenicol under the microscope, blending new theory with real-world medical urgency.
Chloramphenicol’s toxic side looms large. Aplastic anemia casts a long shadow, affecting even healthy adults with unpredictable severity. Gray baby syndrome, another headline risk, creeps up in infants, sometimes with tragic speed. Researchers track down genetic risk factors that tilt the odds toward these adverse reactions, searching for markers in patient populations. The bone marrow suppression links to metabolite build-up, leading toxicologists to pour over liver enzyme pathways in exhaustive detail. Regulators—like the US Food and Drug Administration and Europe’s EMA—demand rigorous post-marketing surveillance and force expensive warnings on packaging, all in pursuit of catching rare but catastrophic outcomes early. This balancing act between powerful antibacterial activity and life-altering toxicity shapes every policy and protocol built around chloramphenicol.
The story of chloramphenicol isn’t finished. Despite newer, shinier antibiotics, the old standby keeps a footprint where poverty or resistance diminish other options. Scientists turn up the pressure to design safer analogues—seeking chemical tweaks or delivery systems that keep its power while shedding its risks. Some work points to engineered bacteria that serve as living drug factories, aiming to reduce costs and greenhouse gas footprints. Drug-resistance experts take lessons from past overuse and campaign for stricter antibiotic stewardship. As conditions like multi-drug resistant typhoid move from headlines to real-world crises, chloramphenicol, refined and cautiously deployed, could see another turn in the treatment spotlight. Global health leaders debate keeping it on the “essential medicines” list, arguing that its price and effectiveness still answer needs many wealthier countries rarely face, making sure research, regulation, and careful medical judgment always guide its next chapter.
Chloramphenicol has been on pharmacy shelves for over seventy years. Doctors once called it a breakthrough, especially for deadly infections like typhoid fever and bacterial meningitis. Today, you won’t find it on the front lines of medicine in places like the United States or Europe. Its reputation dropped after people started reporting serious side effects. Yet, in many parts of the world, chloramphenicol still plays a role that no other antibiotic fills as well, especially where medical resources run thin.
This antibiotic fights bacteria. It works by stopping bacteria from making the proteins they need to grow. Chloramphenicol still treats bugs that dodge newer drugs—typhoid fever, brain infections, even eye and ear bacteria that threaten sight and hearing. The World Health Organization lists it as an essential medicine for treating bacterial meningitis in kids in areas where doctors can’t prescribe third-generation cephalosporins.
What sets chloramphenicol apart? It moves easily through the body, crossing into the brain and spinal fluid where many drugs can’t reach. For diseases like meningitis, where quick action spells the difference between life and death, that kind of reach matters. Eye doctors also rely on chloramphenicol drops to treat conjunctivitis or severe eye infections. In many countries, those drops save vision in clinics unable to stock costlier alternatives.
Chloramphenicol comes with baggage. Doctors worry most about a rare but deadly problem: aplastic anemia. In this condition, the bone marrow stops making enough blood cells. No one can predict who will react in this way. Stories circulate through hospitals about children who survived typhoid but lost their lives to anemia. For this reason, many places use chloramphenicol only when nothing else works or in controlled hospital settings. Routine eye or ear infections usually get milder treatments first, especially in countries with broad access to other drugs.
Some corners of the world, though, can’t always say no to chloramphenicol. Modern antibiotics often cost more or need refrigeration. For remote clinics or crisis zones, this drug offers a lifeline, controlling outbreaks that would otherwise rage unchecked. That is not just a lesson from history books—typhoid and meningitis still take lives in war zones and refugee camps. Here, the choice is often stark: treat with what’s on hand, or watch patients worsen.
From a public health point of view, the focus falls on judicious use. Better diagnostics help doctors decide when to turn to chloramphenicol. Training health workers to look for warning signs and to use the lowest possible effective doses helps contain risks. Investment in infrastructure, like refrigeration for other antibiotics, opens doors for safer alternatives.
Strong stewardship shapes the future of antibiotics. My own time in clinics taught me that every drug—old or new—carries lessons about trade-offs. Chloramphenicol reminds us that access to medicine isn’t just about science. It’s about choices shaped by economics, geography, and the realities front-line workers face. Recognizing these truths can help guide policies that save lives while keeping safety at the center of care.
Chloramphenicol comes up often in talks about older antibiotics. Some people use it to treat serious infections when safer drugs won't do the trick. Doctors sometimes pick chloramphenicol for typhoid or meningitis in places where other treatments fail or cost too much. Its legacy goes back decades; through experience—and tough lessons—medical professionals learned both its strengths and its dangers.
Most folks who take chloramphenicol deal with milder problems like nausea, vomiting, and diarrhea. These digestive headaches show up early and hit everyday life hard. Back when I took care of an older neighbor after a long hospital stay, he spent plenty of time doubled over from queasiness. Meals tasted off, and the bathroom became his second home. A stomach in knots or on edge—hardly a footnote to daily living.
A bigger worry with chloramphenicol is its habit of thinning the blood. The drug messes with bone marrow, the birthplace of blood cells. Bruising becomes easy. Nosebleeds pop up out of nowhere. A cut doesn’t stop bleeding on its own. For people already struggling with platelets, this turns into a real mess. From my time working at a hematology clinic, I remember patients shocked to find purple blotches on their arms after a gentle bump. Mushrooming medical bills following hospital visits for simple nosebleeds aren’t rare either.
Infants stand at special risk. Chloramphenicol can build up in their tiny bodies, causing what's called “gray baby syndrome.” Babies turn ashen, slip into limp weakness, and face dangerous drops in blood pressure. I’ve seen worried parents rush a feverish child to the emergency room, only to learn a single medication dose pushed their baby into crisis. Awareness campaigns in hospitals try to stop these mistakes, but gaps in training still let tragedies through.
Allergies to chloramphenicol catch some patients off guard. Rashes flare up. The face swells. Breathing turns ragged. Once, a coworker at a clinic developed hives and started coughing sharply only hours after his first dose. We rushed him for treatment. Allergic events like this demand quick action and prove how unpredictable old drugs can be.
Blurred vision, headaches, confusion—these symptoms hint at a rarer toxicity from chloramphenicol affecting the nerves or brain. Some survivors of these side effects mention fading eyesight or tingling hands that persist long after the last pill. Doctors run tests and try new treatments, but damage sometimes stays.
No magic fix exists for side effects like these, but solutions do exist. Better blood tests help doctors spot danger early. Electronic prescribing software flags dangerous drug interactions or doses. Education for both doctors and patients keeps risk in check; many clinics now offer simple handouts about what to watch for while on the drug. Seeking help at the first sign of strange bruising, stomach pain, or weakness saves lives.
Chloramphenicol saves lives when nothing else works. That reality doesn’t erase the scars it can leave. Trust and open talk between patient and doctor blunt much of the danger. Shorter treatment regimens, strict monitoring, and only using this drug when no safer choice exists makes tough side effects less common. Instead of trusting old medicine blindly, we keep asking tough questions, looking for better answers, and putting the patient front and center.
Chloramphenicol stands out as an antibiotic trusted in both eye and ear infections, and sometimes even for serious bacterial problems when other medicines don’t work. Its story goes back decades, yet mistakes in using it still pop up everywhere. A lot of folks want to skip directions or self-medicate, but the rules around this medicine exist for a reason.
Doctors rarely hand out the oral version outside of strict supervision. That choice comes from well-documented risks—too much, and blood trouble shows up, too little, and it invites bacterial resistance. Chloramphenicol capsules need swallowing whole with water, not breaking or chewing. Sticking to the schedule holds real importance for clearing infections: no doubling up missed doses, no stopping early “just because you feel a bit better.” Even one skipped dose risks letting the bacteria come back stronger and nastier.
It’s also not a good idea to mix chloramphenicol with alcohol or other medications without medical advice. Complications like bone marrow suppression are well documented in scientific literature, and doctors take pains to trace your health background for this reason. Medical history, allergies, pregnancy, and age factor in each prescription.
As someone who’s had to use these eye drops, I can say the instructions aren’t optional. Washing your hands before and after every use stops other germs from getting in. Pull down the lower eyelid gently to create a pocket, then let the drop land—don’t poke or let the tip touch your eye or skin. Closing your eye for a moment lets the medicine settle.
Many people rush through this, but it pays to wait a couple of minutes before putting in other eye drops. The same caution goes for the ointment: squeeze a thin line inside the lower lid, not on the eyelashes. Seeing blurry for a bit is normal—that means the ointment’s still spreading.
Contacts should come out and only go back in after several hours or when your doctor says it’s safe. Ignoring that often leads to re-infection or eye irritation, both easily avoided by sticking to the plan.
Medical mistakes don’t just hurt one person. Overuse and incorrect use of antibiotics add to the wider problem of resistance. Infections once treatable can spiral into serious hospital stays. In my community, some families lost months fighting relapses for children because of interrupted or misused chloramphenicol. The World Health Organization fills reports each year with these cases.
Respecting this medicine’s power comes down to routine—following the full treatment, skipping home remedies, never reusing old leftovers, and reporting any signs like skin rashes or new bleeding to a medical team right away.
Doctors, nurses, and pharmacists have their job cut out, repeating information to every patient. Still, the responsibility spreads out—patients learn best when instructions are clear and practical. Real stories, posters in clinics, and clear written guides in local languages boost understanding. Pharmacies that check for repeat purchases and remind people about dangers add another layer of prevention. This effort keeps older antibiotics like chloramphenicol safe and helpful for those who really need them.
Many parents worry about what goes into their children's bodies. Chloramphenicol sometimes comes up in those anxious conversations. This antibiotic knocked out serious infections back in the day, and for a long time doctors saw it as a go-to weapon when nothing else seemed to work. These days, hearing the name often triggers more concern than comfort, especially in households with kids or expectant mothers.
My first experience with chloramphenicol as a parent brought a wave of questions. Decades ago, this drug cleared up typhoid fever and other tough illnesses, even in children. The trouble started when doctors noticed a handful of young patients fell dangerously ill after treatment. Some developed a bone marrow problem called aplastic anemia. This condition, where the body stops producing enough blood cells, remains life-threatening. The link between chloramphenicol and this reaction looks rare, but when dealing with kids, even small risks weigh heavily.
Scientific reviews support that most children tolerate the medicine, but the risk of fatal side effects sits higher with this drug than with modern antibiotics. Newborns track as the most vulnerable. Their livers struggle to clear the drug fast enough, leading to “gray baby syndrome”—a medical emergency seen in the 1950s and 60s that marked the start of stricter rules. Fatal complications dropped sharply when doctors reduced use in infants and reserved chloramphenicol for specific cases where nothing else could save a life.
Pregnant women face their own risks. Chloramphenicol crosses the placenta, exposing the unborn child. In animal studies and real-life reports, the medicine has affected fetal bone marrow growth. Even without robust human evidence from trials—no parent volunteers their unborn child for such studies—it makes sense that most guidelines recommend steering clear during pregnancy, unless fighting life-threatening infections with no better options.
The goal in pediatric and maternity wards revolves around avoiding unnecessary dangers. The World Health Organization still recommends chloramphenicol for certain life-threatening infections like meningitis in areas without other drugs. In wealthier countries, safer and just-as-effective antibiotics beat this one out for routine use. For me and many doctors I know, antibiotics like amoxicillin and ceftriaxone remove much of the anxiety that chloramphenicol brings.
Too often, fear overrules information. Families deserve honest guidance based on trusted studies and decades of clinician experience. Chloramphenicol’s danger in children and pregnant women does not mean it’s poison, but rather that its place belongs in last-line situations. Pharmacists, pediatricians, and obstetricians put thought and care into prescriptions. The heavy history with chloramphenicol shaped today’s tough standards for drug safety—those rules protect some of society’s most vulnerable.
Modern medicine pushes for evidence, not just tradition. Large-scale studies, from the CDC and European Medicines Agency, show how newer antibiotics bring down serious side effects. Medical professionals keep learning, staying current with global guidelines and local realities. The chloramphenicol story reminds us why questions about medicines matter and why honesty from healthcare providers builds trust. Protecting kids and unborn babies involves more than hand-me-down wisdom: it calls for clear answers, careful choices, and always, a bit of humility.
Chloramphenicol remains in use, even after all these years, mostly for serious bacterial infections that don’t seem to go away with easier options. My old pharmacology professor used to call it "the antibiotic of last resort." This heavy hitter can knock out things like typhoid fever and meningitis in stubborn cases, which makes it sound pretty great. At the same time, it also means there is a risk for some serious side effects. One of the most concerning issues involves how chloramphenicol mixes with other medications. Seems like almost every tool in medicine comes with some trade-off.
I’ve seen firsthand how easily problems can pop up with medicines that hang around in the body. Chloramphenicol goes through the liver to get broken down. That’s the body’s main detox center, and it depends on a family of enzymes called cytochrome P450. Other drugs, including common medicines—from blood thinners like warfarin to seizure meds such as phenytoin—use the same machinery. Chloramphenicol tends to slow down this enzyme activity. So, when someone takes chloramphenicol with warfarin, it can crank up warfarin levels in the bloodstream, leading to more frequent bleeding episodes. Even eating a healthy diet won’t prevent this kind of problem, and doctors sometimes have to keep a close eye on someone’s blood work just to keep things safe.
People who depend on a steady balance with antiepileptic drugs can run into issues if chloramphenicol hangs around in their system. A patient I knew lost seizure control after starting antibiotics, with blood levels of their seizure medication climbing high enough to warrant a trip back to the emergency room. Chloramphenicol can trigger bone marrow suppression, and drugs like sulfonamides or cytotoxic agents add fuel to the fire. If both hit the marrow, blood counts drop, and folks start feeling weak or even develop infections simply because their white cell count goes dangerously low. This is no place for guesswork.
People sometimes forget about the nonprescription stuff—over-the-counter painkillers, cold remedies, even natural supplements. Some products can change how drugs get absorbed or slow down enzymes, so reading the back of the bottle doesn’t always tell the full story. For example, acetaminophen and chloramphenicol both rely on the liver, so stacking them up can overwhelm the system in someone with borderline liver function. Patients with any history of liver problems, young children, and the elderly walk a thinner line, especially if they pick up something extra at the pharmacy.
The most practical advice anyone gave me, both as a patient and a health worker, was to be honest about every pill and supplement on the list. Bring the bag to the clinic if needed. Electronic health records help, but they miss things if the whole story isn’t there. Pharmacists can often spot classic mistakes that sneak past busy clinics. Bloodwork—especially with drugs that affect clotting or immune function—provides an extra layer of confidence when juggling risky combinations.
Chloramphenicol keeps its place for a reason, yet anyone who prescribes it or takes it has to respect its stubborn personality. The risk of drug interaction is no small thing. Staying alert, double-checking every new prescription, and keeping up honest communication between patients and professionals all pay off. Real experience says you learn more from the people who ask lots of questions, not from those who pretend to know it all.
| Names | |
| Preferred IUPAC name | 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide |
| Other names |
Chloromycetin Paraxin Fenicol Chlorocid Chlormycetin |
| Pronunciation | /klɔːˌræm.fəˈnɪk.əl/ |
| Identifiers | |
| CAS Number | 56-75-7 |
| 3D model (JSmol) | `/JSmol/data/cml/chloramphenicol.cml` |
| Beilstein Reference | 1362204 |
| ChEBI | CHEBI:17698 |
| ChEMBL | CHEMBL95 |
| ChemSpider | 2118 |
| DrugBank | DB00446 |
| ECHA InfoCard | 100.034.207 |
| EC Number | 3.1.1.43 |
| Gmelin Reference | 7439 |
| KEGG | C1380 |
| MeSH | D002683 |
| PubChem CID | 5959 |
| RTECS number | GN6476000 |
| UNII | 7CEP7GOE1A |
| UN number | UN2550 |
| Properties | |
| Chemical formula | C11H12Cl2N2O5 |
| Molar mass | 323.13 g/mol |
| Appearance | White or yellowish-white crystalline powder |
| Odor | Odorless |
| Density | 1.14 g/cm³ |
| Solubility in water | 0.25 g/100 mL (20 °C) |
| log P | 1.14 |
| Vapor pressure | <0.0000001 mm Hg (25°C) |
| Acidity (pKa) | 11.5 |
| Basicity (pKb) | 5.5 |
| Magnetic susceptibility (χ) | -92.0e-6 cm³/mol |
| Refractive index (nD) | 1.627 |
| Viscosity | Viscous liquid |
| Dipole moment | 2.41 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 357.2 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -226.8 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -4637.2 kJ/mol |
| Pharmacology | |
| ATC code | J01BA01 |
| Hazards | |
| Main hazards | May cause allergic reactions; toxic if swallowed, inhaled, or absorbed through skin; may cause bone marrow suppression; possible carcinogen. |
| GHS labelling | GHS02, GHS07, GHS08 |
| Pictograms | GHS06, GHS08 |
| Signal word | Warning |
| Hazard statements | H302, H317, H351 |
| Precautionary statements | P264, P280, P302+P352, P305+P351+P338, P332+P313, P337+P313, P362+P364 |
| NFPA 704 (fire diamond) | 2-2-0 |
| Flash point | 79.7°C |
| Autoignition temperature | > 438 °C |
| Lethal dose or concentration | LD50 oral rat 2500 mg/kg |
| LD50 (median dose) | LD50 (median dose): 2500 mg/kg (oral, rat) |
| NIOSH | WU4375000 |
| PEL (Permissible) | PEL: 5 mg/m³ |
| REL (Recommended) | 1.0% |
| IDLH (Immediate danger) | Unknown |
| Related compounds | |
| Related compounds |
Thiamphenicol Florfenicol |
